4-Methylbenzimidamide

4-Methylbenzimidamide

SCHEMBL1050355

Cc1ccc(C(=N)N)cc1.O=S(=O)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.51
PRSS1 P07477 5/20 0.47
PRSS3 P35030 5/20 0.47
PRSS2 P07478 4/20 0.47
F2 P00734 3/20 0.47
PLAU P00749 6/20 0.47
HPN P05981 5/20 0.47
LMNA P02545 2/20 0.46
MASP2 O00187 1/20 0.46
THPO P40225 1/20 0.46
MRGPRX1 Q96LB2 1/20 0.46
C1S P09871 1/20 0.45
APEX1 P27695 1/20 0.45
ST14 Q9Y5Y6 1/20 0.43
PRMT5 O14744 1/20 0.43
PRMT1 Q99873 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Methylbenzimidamide SCHEMBL15844882 0.98 NQO2 (0.50) NQO2PRSS1PRSS3PRSS2F2
4-Methylbenzimidamide SCHEMBL524027 0.87 LMNA (0.59) NQO2PRSS1PRSS3PRSS2F2
4-Methylbenzimidamide SCHEMBL1019464 0.84 PRSS1 (0.61) NQO2PRSS1PRSS3PRSS2F2
4-Methylbenzimidamide SCHEMBL28504756 0.84 PRSS1 (0.61) NQO2PRSS1PRSS3PRSS2F2
SCHEMBL8558497 0.84 GAA (0.61) NQO2PRSS1PRSS3PRSS2F2
SCHEMBL8127463 0.82 CYP2D6 (0.55) NQO2PRSS1PRSS3PRSS2F2
4-Methylbenzimidamide SCHEMBL1436204 0.82 LMNA (0.54) NQO2PRSS1PRSS3PRSS2F2
4-Methylbenzimidamide SCHEMBL28496422 0.82 PRSS1 (0.58) NQO2PRSS1PRSS3PRSS2F2
SCHEMBL12461484 0.80 WDR5 (0.64) NQO2PRSS1PRSS3PRSS2F2
SCHEMBL9029471 0.78 HPN (0.50) NQO2PRSS1PRSS3PRSS2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7867699-B2 Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby WYETH (US) 2011-01-11 US disclosed
US-20060035827-A1 Compositions and methods for the treatment or prevention of gallbladder disease NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2006-02-16 US disclosed
WO-2005095448-A2 METHOD OF SYNTHESIZING AND PURIFYING DKK PROTEINS AND DKK PROTEINS OBTAINED THEREBY OSCIENT PHARMACEUTICALS CORPORATION (US) 2005-10-13 WO disclosed
US-5324648-A Anticoagulants; antitumor agents GEORGIA TECH RESEARCH CORPORATION (US) 1994-06-28 US disclosed
US-5120715-A Treating with crosslinked cellulose or agarose sulfate TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-09 US disclosed
US-4954519-A Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents GEORGIA TECH RESEARCH CORPORATION (US) 1990-09-04 US disclosed
EP-0373540-A2 Method for purifying fibroblast growth factor protein Takeda Chemical Industries, Ltd. (JP) 1990-06-20 EP disclosed
WO-1990002175-A1 A METHOD OF PRODUCING POLYPEPTIDES BY CULTURING EUKARYOTIC CELLS IN THE PRESENCE OF PROTEASE INHIBITORS NOVO NORDISK A/S (DK) 1990-03-08 WO disclosed
US-4845242-A ANTITUMOR GEORGIA TECH RESEARCH CORPORATION (US) 1989-07-04 US disclosed
EP-0301458-A2 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses NEW YORK UNIVERSITY (US) 1989-02-01 EP disclosed